Myopia Treatment Devices Market Report and Forecast 2025-2034

The global myopia treatment devices market was valued at USD 18.02 Billion in 2024, driven by the rising prevalence of myopia across the globe. The market is anticipated to grow at a CAGR of 7.80% during the forecast period of 2025-2034, with the values likely to reach USD 38.19 Billion by 2034.

Myopia Treatment Devices Market Overview

Myopia treatment devices are innovative tools designed to slow the progression of myopia (short-sightedness) and improve vision clarity. Common devices include orthokeratology (Ortho-K) lenses, worn overnight to temporarily reshape the cornea, and multifocal contact lenses, which manage peripheral defocus to reduce eye elongation. Atropine eye drops, a pharmacological option, are sometimes considered part of treatment devices due to their use in conjunction with optical methods. Advanced technologies like myopia control spectacle lenses and light-based devices regulate visual stimuli to address eye growth. These solutions aim to prevent high myopia complications and are tailored to individual needs, especially in children.

Myopia Treatment Devices Market Growth Drivers

Innovation and Strategic Acquisitions Enhance Market Growth Potential

The rising prevalence of myopia, especially in children, and the continuous drive towards innovative healthcare solutions are key market drivers. For instance, In January  2025, EssilorLuxottica took a significant step by acquiring Pulse Audition, a French startup focused on AI-based noise reduction and voice enhancement. This acquisition integrates Pulse Audition’s expertise in AI and audio signal processing with EssilorLuxottica’s existing hardware and software, improving the quality of its products. By blending advanced technologies in hearing and vision care, this acquisition is expected to enhance the myopia treatment devices market. Over the forecast period, this will boost market growth as companies develop smarter, more integrated solutions for myopia management.

Surge in Strategic Initiatives by Leading Companies to Propel Myopia Treatment Devices Market Development

The growing focus on effective myopia treatments for pediatric patients and the increasing awareness of its progression risks are accelerating market demand. For instance, In January  2024, Eyenovia, Inc. re-acquired the rights to MicroPine, an investigational ophthalmic spray designed to slow the progression of pediatric myopia. MicroPine uses atropine, a well-known agent proven to reduce myopia progression by up to 60%. With over 25 million children in the U.S. affected by myopia, and many at risk of progressive myopia, this acquisition addresses a significant gap in treatment. Eyenovia’s commitment to bringing this treatment to market will drive growth in the global myopia treatment devices sector, particularly as the demand for effective and FDA-approved therapies increases.

Launch of New Products to Enhance Myopia Treatment Devices Market Value

The increasing prevalence of myopia, particularly among children, and the growing importance of outdoor activities in slowing progression are key factors driving market growth. For instance, In May 2023 , HOYA Vision Care launched the MiYOSMART Sun lenses in Canada, expanding its global reach. These lenses, incorporating DIMS Technology, are designed to slow myopia progression while providing UV protection and encouraging outdoor activity. By integrating photochromic and polarised lenses, the product addresses myopia progression while promoting healthy lifestyle habits. HOYA’s expansion into international markets and the ongoing evidence supporting outdoor activities as a key factor in myopia management will fuel the growth of the global myopia treatment devices market over the forecast period.

Myopia Treatment Devices Market Trends

The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:

Rising Demand for Non-Invasive Myopia Treatment Solutions Driving Market Growth

The market is witnessing significant growth due to the rising demand for non-invasive solutions. Devices such as orthokeratology (Ortho-K) lenses and advanced spectacles are gaining popularity among patients seeking effective alternatives to surgical treatments. Increased awareness of myopia-related complications, coupled with a growing preference for minimally invasive technologies, is driving innovation in this space. Additionally, expanding access to these devices in emerging markets has boosted adoption rates. This trend reflects the need for convenient, patient-friendly options to address the global myopia burden while improving treatment outcomes and enhancing the patient experience.

Technological Advancements to Boost Myopia Treatment Devices Market Value

Technological advancements are significantly shaping the development of myopia treatment devices. Integration of artificial intelligence (AI) and machine learning (ML) in diagnostic tools enables accurate myopia progression monitoring and personalised treatment plans. Innovations such as smart contact lenses and light-modulating glasses are addressing unmet needs in early intervention and long-term myopia control. Collaboration between research institutions and device manufacturers is accelerating the commercialisation of cutting-edge products. As these technologies gain regulatory approval, they are expected to create new opportunities, enhancing the global market's development and enabling efficient, tailored solutions for managing the increasing prevalence of myopia worldwide.

Rising Investments in Research and Development to Augment Myopia Treatment Devices Market Size

The market is experiencing a surge in value due to increased investments in research and development (R&D). Leading industry players and startups are channelling resources into developing innovative products, such as atropine-dispensing devices and wearable tech solutions, to address myopia's rising prevalence. Public-private partnerships and government grants further incentivise advancements in this area. As novel devices reach the market, their potential to reduce healthcare costs by mitigating long-term complications ensures strong adoption. This trend underscores the critical role of sustained R&D investments in enhancing the market’s value and addressing evolving patient needs effectively.

Growing Awareness and Healthcare Infrastructure Supporting Myopia Treatment Devices Market Growth

Rising awareness of the importance of early myopia management is driving the global adoption of treatment devices. Campaigns by healthcare organisations and educational institutions are spreading knowledge about the risks of unmanaged myopia, prompting timely interventions. Additionally, improved healthcare infrastructure, particularly in developing regions, supports the accessibility and affordability of treatment devices. Government initiatives to incorporate myopia management into national health programmes further bolster market expansion. This trend highlights the critical role of awareness initiatives and strengthened healthcare frameworks in promoting the adoption of advanced myopia treatment solutions, ensuring a more comprehensive approach to addressing global eye health concerns.

Myopia Treatment Devices Market Segmentation

Myopia Treatment Devices Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:

Market Breakup by Product Type

• Eyeglasses
• Contact Lenses
• Ortho-K Lenses
• Phakic Intraocular Lenses
• Excimer Laser Refractive Surgery Devices
• Femtosecond Lasers

Market Breakup by Population Type

• Adult
• Child

Market Breakup by Type

• Refractive Myopia
• Axial Myopia

Market Breakup by End User

• Hospitals and Clinics
• Specialty Clinics
• Ophthalmology Centers
• Others

Market Breakup by Distribution Channel

• Online
• Offline

Market Breakup by Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Myopia Treatment Devices Market Share

Eyeglasses to Hold a Substantial Share of the Market Based on Product Type

Eyeglasses are predicted to dominate the product type segment due to their widespread use for vision correction, affordability, and accessibility. Technological advancements in lens materials and designs have further boosted adoption. Increasing cases of refractive errors like myopia and presbyopia globally are key drivers. Moreover, their non-invasive nature and compatibility across diverse demographics make eyeglasses the preferred solution. As awareness of eye health grows, especially in developing regions, this segment is expected to maintain its leading position, driving market growth through innovative products and expanding consumer bases.

Adults to Dominate the Myopia Treatment Devices Market Segmentation by Population Type

The adult segment holds the largest market share, driven by the high prevalence of age-related vision disorders like cataracts, myopia, and presbyopia. Adults are more likely to seek treatment or preventive measures due to occupational demands and lifestyle-related eye issues. Growing geriatric populations globally also contribute to this segment’s dominance. Increasing awareness and access to advanced eye care solutions in urban areas further fuel growth. With the rise in disposable incomes and focus on preventive health, the adult population segment will continue driving the market in the forecast period.

Refractive Myopia to Lead the Segmentation by Type

Refractive myopia is one of the leading segments by type due to its high prevalence worldwide, particularly among younger populations engaged in extensive screen use. Increased awareness and early diagnosis, supported by advanced refractive correction technologies, have propelled this segment. Rising urbanisation, prolonged near-work activities, and a surge in optometric services globally are driving growth. Innovations in non-invasive treatments and corrective lenses, alongside government health initiatives, are expected to sustain its dominance. The focus on reducing myopia-associated complications ensures refractive myopia remains a significant growth driver in the forecast period.

Hospitals and Clinics Leading End User Segmentation

Hospitals and clinics dominate the end-user segment in the myopia treatment devices market, benefiting from comprehensive facilities and a high influx of patients. They offer advanced diagnostic tools and treatments for myopia and other eye disorders, providing convenience and reliability. Strong partnerships with technology providers and healthcare systems enable integrated Big Data solutions, enhancing patient outcomes. The increasing adoption of electronic health records (EHRs) and telemedicine within hospitals boosts this segment further. As demand for specialised eye care rises, hospitals and clinics are well-positioned to continue leading market growth.

Offline Channels to Dominate the Myopia Treatment Devices Market Share by Distribution Channel

Offline channels are estimated to lead the distribution segment due to their accessibility, trust, and ability to provide hands-on product experience. Opticians, speciality stores, and clinics ensure personalised services, aiding consumer confidence in purchasing corrective eyewear. Despite the growth of online platforms, offline channels remain preferred for high-value products like eyeglasses and surgical devices. The availability of expert consultations and immediate product adjustments adds value. As eye care awareness expands, particularly in developing countries, offline distribution is expected to drive the market, leveraging its established consumer base and local presence.

Myopia Treatment Devices Market Analysis by Region

Asia Pacific is expected to witness significant growth in the forecast period driven by the region’s high prevalence of myopia, especially among children and young adults. Urbanisation, extensive screen use, and intense academic pressures contribute to increasing cases of myopia. Countries like China, Japan, and South Korea have advanced healthcare infrastructures supporting the adoption of treatment devices such as ortho-k lenses and refractive surgery tools. Government initiatives promoting eye health awareness and accessibility to advanced diagnostic and treatment technologies further bolster market growth. Additionally, rising disposable incomes and a growing middle class enable more individuals to seek corrective treatments, ensuring Asia Pacific remains a dominant force in the market during the forecast period.

Leading Players in the Myopia Treatment Devices Market

The key features of the market report comprise patent analysis, grant analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:

CooperVision

Headquartered in Pleasanton, California, CooperVision was established in 1980 and is a leading player in vision care. The company specialises in the design and manufacture of contact lenses, including innovative myopia control solutions like MiSight® 1 day lenses. CooperVision's portfolio also includes soft contact lenses for astigmatism and presbyopia, with a focus on advanced material technologies. It collaborates with healthcare professionals globally, promoting eye health through cutting-edge products. CooperVision’s dedication to addressing myopia’s growing prevalence has positioned it as a key innovator in myopia treatment devices.

Johnson & Johnson Services, Inc.

Founded in 1886, Johnson & Johnson Services, Inc. is headquartered in New Brunswick, New Jersey, and is renowned for its healthcare innovations. Its vision care division, Johnson & Johnson Vision, offers solutions for myopia management, including Acuvue® contact lenses and surgical devices. The company emphasises research-driven advancements to improve eye health and reduce myopia progression. Johnson & Johnson’s vast global presence and strong portfolio across pharmaceuticals, medical devices, and consumer health products make it a significant contributor to the global myopia treatment devices market.

Essilor International

Essilor International, established in 1972 and headquartered in Charenton-le-Pont, France, is a global leader in ophthalmic optics. Its portfolio includes innovative spectacle lenses, such as Essilor Stellest™, designed for myopia control. The company pioneers advanced lens technologies to improve vision and address the myopia epidemic, particularly among younger populations. With a strong commitment to sustainability and accessible vision care, Essilor combines innovation with global outreach. Its collaborations with eye care professionals and research initiatives make it a key player in myopia treatment devices worldwide.

Bausch & Lomb Inc.

Headquartered in Rochester, New York, and established in 1853, Bausch & Lomb is a prominent name in eye health. The company’s portfolio includes contact lenses, lens care products, and surgical devices for treating myopia and other vision disorders. Innovations such as Ortho-K lenses for myopia control underscore its expertise. With a focus on research, Bausch & Lomb continuously develops solutions to enhance eye care. Its global presence and diverse offerings in vision correction devices make it a cornerstone of the myopia treatment devices market.

Other key players in the market include Lucid Korea Co., Ltd., Euclid Systems Corp., Nidek Co., Ltd., Schwind Eye Tech Solutions GmbH, SightGlass Vision, Inc., and Abb Optical Group.

Key Questions Answered in the Myopia Treatment Devices Market

• What was the global myopia treatment devices market value in 2024?
• What is the global myopia treatment devices market forecast outlook for 2025-2034?
• What is market segmentation based on product type?
• How is the market segmented based on population type?
• What is market segmentation based on type?
• How is the market segmented based on end users?
• What is market segmentation based on distribution channels?
• What are the major factors aiding the global myopia treatment devices market demand?
• How has the market performed so far and how is it anticipated to perform in the coming years?
• What are the market's major drivers, opportunities, and restraints?
• What are the major global myopia treatment devices market trends?
• Which product type will lead the market segment?
• Which population type will lead the market segment?
• Which type will lead the market segment?
• Which end user will lead the market segment?
• Which distribution channel will lead the market segment?
• Who are the key players involved in the global myopia treatment devices market?
• What is the patent landscape of the market?
• What are the current unmet needs and challenges in the market?
• How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?